Market by Phase Type, Service, Sponsor, and Country Outlook | Forecast 2022-2028
Triton Market Research, in its report, has concluded that North America’s clinical trials support services would advance with a CAGR of 7.39% in the projected period from 2022 to 2028.
The countries assessed in this region include:
• The United States
• Canada
The
United States accounted for the largest revenue share in the North American
market in 2021. According to data from industry sources,
close to 46% of the global drug sales in 2020 were accredited to the region. By
conducting their studies in a market like North America, which is technologically
advanced and has a robust infrastructure, organizations are more likely to
receive regulatory approval and gain access to the world’s largest
pharmaceutical market.
The
United States is the hub of clinical trials as most companies that offer
support services for efficiently conducting these trials are headquartered here.
There has been a notable rise in the number of registered studies for clinical
trials over the years. For instance, in 2000, nearly 2,119 registered studies
were available. And by 2022, this number has increased to 4,17,874 registered
studies. The different types of available registered studies are focused on
drugs or biologicals, medical devices, surgical procedures, etc.
CROs offer various services and solutions to effectively maintain data for
registering these studies. This is expected to aid the growth of the market in
the US.
Canada is globally
renowned for the skills and expertise of its research clinicians. Thus, most of
the major multinational pharmaceutical companies carry out a large portion of
their clinical trials in the country. The strong investments in the Canadian market
can also be attributed to its well-developed healthcare system known, strong
focus on education, and so on. Being one of the top-preferred destinations for
conducting clinical trials, the demand for support services in the nation is
also high in the nation. This is expected to consolidate the studied market’s
growth in the years to come.
After performing the phase
I clinical trial and receiving approval for the phase II clinical trial, the
main goal is to monitor the amount of dosage that would be preferable and
effective for disease treatment. Compared to the phase I trials, a large number
of patients participate voluntarily in the phase II trials, so less common side
effects are likely to be seen. Usually, the patients or participants are
assigned to different treatment groups, where each group receives different
doses and treatments.
Triton’s
report assesses the market based on phase type, sponsor, and service.
Here, the phase type segment comprises phase I, phase II, phase III, and phase
IV.
The
eminent names in the clinical trials support services market include Advanced
Clinical, Syneos Health, Clinipace, Alcura, Parexel, KCR, and Charles River
Laboratories.
Syneos Health is the
only organization in this field that offers fully integrated biopharmaceutical
solutions purpose-built for its clients. It operates in two main segments: Solutions
and Therapeutic Expertise. Within the solutions segment, it provides
bioanalytical solutions, decentralized solutions, phase I solutions, phase II-III
a solutions, phase III b-IV solutions, and so on. The US-based company was founded
in 1998 and is headquartered in Morrisville, North Carolina.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2022-2028
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the clinical trials support services market
revenue growth in North America and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces Analysis Model
·
A
wide-ranging study of factors that will challenge the North America clinical
trials support services market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& AGREEMENTS
2.9.4. INVESTMENTS
& EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET
CHALLENGES
2.11.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF
OPEN-SOURCE SOFTWARE
2.12. MARKET
OPPORTUNITIES
2.12.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. NORTH
AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. NORTH
AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER
SERVICES
5. NORTH
AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. NORTH
AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED
STATES
6.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI
APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT
LAUNCHES
TABLE 7: LIST OF CONTRACTS
& AGREEMENTS
TABLE 8: LIST OF INVESTMENTS
& BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE
SOFTWARE
TABLE 11: LAUNCH OF MEDICAL
DRUGS
TABLE 12: PROMISING
ACQUISITIONS IN THE MARKET
TABLE 13: NORTH AMERICA
CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA CLINICAL
TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $
MILLION)
TABLE 17: NUMBER AND TYPES OF
REGISTERED STUDIES
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021
& 2028 (IN %)
FIGURE
5: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028
(IN $ MILLION)
FIGURE
6: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II,
2022-2028 (IN $ MILLION)
FIGURE
7: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III,
2022-2028 (IN $ MILLION)
FIGURE
8: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV,
2022-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021
& 2028 (IN %)
FIGURE
10: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL
SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
11: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE
SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
12: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT
RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
13: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY
SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
14: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT,
2022-2028 (IN $ MILLION)
FIGURE
15: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
16: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021
& 2028 (IN %)
FIGURE
17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE
COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS,
2022-2028 (IN $ MILLION)
FIGURE
20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK,
2021 & 2028 (IN %)
FIGURE
21: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2028 (IN $
MILLION)
FIGURE
22: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2028 (IN $ MILLION)